TY - JOUR
T1 - Gastric adenocarcinoma burden and late-stage diagnosis in Latino and non-Latino populations in the United States and Texas, during 2004–2016
T2 - A multilevel analysis
AU - Long Parma, Dorothy
AU - Schmidt, Susanne
AU - Muñoz, Edgar
AU - Ramirez, Amelie G.
N1 - Funding Information:
This work was supported by a Department of Defense Peer-reviewed Cancer Research Program Career Development Award (W81XWH1910215) to DLP, Redes En Acción: The National Latino Cancer Research Network (U01 CA86117 and U54 CA153511) and The Cancer Center Support Group of the Mays Cancer Center at The University of Texas Health Science at Center San Antonio (P30 CA054174). Thanks to Helen L. Foster and Eric E. Moffett, for assistance with conversion of ICD codes; and Larissa Aroche-Gutierrez and Gustavo F. Westin, for help with earlier manuscript versions.
Funding Information:
This work was supported by a Department of Defense Peer‐reviewed Cancer Research Program Career Development Award (W81XWH1910215) to DLP, : The National Latino Cancer Research Network (U01 CA86117 and U54 CA153511) and The Cancer Center Support Group of the Mays Cancer Center at The University of Texas Health Science at Center San Antonio (P30 CA054174). Redes En Acción
Publisher Copyright:
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2021/9
Y1 - 2021/9
N2 - Background: Gastric cancer disproportionately affects Latinos, but little is known about regional effects and risk factors. We compared primary incidence, late-stage diagnosis, and risk factors for gastric adenocarcinoma (GCA) from 2004 to 2016 in Latinos and non-Latinos in the United States, Texas (TX), and South Texas (STX). Methods: We collected case data from Surveillance, Epidemiology, and End Results (SEER) and the Texas Cancer Registry. We generated average annual age-adjusted incidence rates, rate ratios (RRs), and 95% confidence intervals (CIs) using SEER*Stat software and analyzed the cases by anatomic site, demographics, and county-level risk factors using SAS 9.4. We constructed multilevel logistic regression models for late-stage GCA, adjusting for patient- and county-level characteristics. Results: Latinos had higher overall GCA incidence rates in all regions, with the greatest disparities in overlap GCA in STX males (RR 4.39; 95% CI: 2.85, 6.93). There were no differences in cardia GCA rates for non-Hispanic Whites (NHWs) and Latino women in all regions. Younger patients, patients with overlapping or not otherwise specified (NOS) lesions, and patients diagnosed during 2012–2016 had higher odds of late-stage GCA. The stratification by location showed no differences in late-stage disease between NHWs and Latinos. The stratification by anatomic site showed Latinos with cardia GCA were more likely to have late-stage GCA than NHWs (OR: 1.13, p = 0.008). At the county level, higher odds of late-stage GCA were associated with medium and high social deprivation levels in TX without STX (OR: 1.25 and 1.20, p = 0.007 and 0.028, respectively), and medium social deprivation index (SDI) in patients with NOS GCA (OR: 1.21, p = 0.01). Conclusions: STX Latinos experience greater GCA disparities than those in TX and the United States. Younger age and social deprivation increase the risk for late-stage GCA, while Latinos and women are at higher risk specifically for late-stage cardia GCA. There is a need for population-specific, culturally responsive intervention and prevention measures, and additional research to elucidate contributing risk factors.
AB - Background: Gastric cancer disproportionately affects Latinos, but little is known about regional effects and risk factors. We compared primary incidence, late-stage diagnosis, and risk factors for gastric adenocarcinoma (GCA) from 2004 to 2016 in Latinos and non-Latinos in the United States, Texas (TX), and South Texas (STX). Methods: We collected case data from Surveillance, Epidemiology, and End Results (SEER) and the Texas Cancer Registry. We generated average annual age-adjusted incidence rates, rate ratios (RRs), and 95% confidence intervals (CIs) using SEER*Stat software and analyzed the cases by anatomic site, demographics, and county-level risk factors using SAS 9.4. We constructed multilevel logistic regression models for late-stage GCA, adjusting for patient- and county-level characteristics. Results: Latinos had higher overall GCA incidence rates in all regions, with the greatest disparities in overlap GCA in STX males (RR 4.39; 95% CI: 2.85, 6.93). There were no differences in cardia GCA rates for non-Hispanic Whites (NHWs) and Latino women in all regions. Younger patients, patients with overlapping or not otherwise specified (NOS) lesions, and patients diagnosed during 2012–2016 had higher odds of late-stage GCA. The stratification by location showed no differences in late-stage disease between NHWs and Latinos. The stratification by anatomic site showed Latinos with cardia GCA were more likely to have late-stage GCA than NHWs (OR: 1.13, p = 0.008). At the county level, higher odds of late-stage GCA were associated with medium and high social deprivation levels in TX without STX (OR: 1.25 and 1.20, p = 0.007 and 0.028, respectively), and medium social deprivation index (SDI) in patients with NOS GCA (OR: 1.21, p = 0.01). Conclusions: STX Latinos experience greater GCA disparities than those in TX and the United States. Younger age and social deprivation increase the risk for late-stage GCA, while Latinos and women are at higher risk specifically for late-stage cardia GCA. There is a need for population-specific, culturally responsive intervention and prevention measures, and additional research to elucidate contributing risk factors.
KW - Latinos
KW - gastric adenocarcinoma
KW - health disparities
KW - late-stage disease
KW - multilevel analysis
UR - http://www.scopus.com/inward/record.url?scp=85112773879&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112773879&partnerID=8YFLogxK
U2 - 10.1002/cam4.4175
DO - 10.1002/cam4.4175
M3 - Article
C2 - 34409764
AN - SCOPUS:85112773879
SN - 2045-7634
VL - 10
SP - 6468
EP - 6479
JO - Cancer Medicine
JF - Cancer Medicine
IS - 18
ER -